FRIDAY OCTOBER 7
08:45 Opening ceremony. Patrizio Lancellotti – See presentation
08:50 Local host presentation of the venue. Madalina Garbi – See presentation
09:00 – 10:30 DEBATES ON HEART VALVE DISEASE DIAGNOSIS AND MANAGEMENT
09:00 That this House believes disease staging should replace categorical grading of valve lesions.
Chairs: Mani Vannan, Gilbert Habib
Proposition: Marie-Annick Clavel – See presentation | Expert Panel: Mathieu Lempereur, Jadranka Separovic
Opposition: Guy Lloyd – See presentation | Expert Panel: Eustachio Agricola, Alain Berrebi
09:30 That this House believes AS may be treated by preventing aortic valve calcification.
Chairs: Patrizio Lancellotti, Marie-Annick Clavel
Proposition: Cecile Oury – See presentation | Expert Panel: Marc Dweck, Benoy Shah
Opposition: Philippe Pibarot – See presentation | Expert Panel: Augustin Coisnes, Mani Vannan
10:00 That this House believes AVR/TAVI should be offered without waiting for symptoms in severe AS.
Chairs: James Rudd, Patrizio Lancellotti
Proposition: Marc Dweck – See presentation | Expert Panel: Pierluigi Costanzo, Augustin Coisnes
Opposition: Benoy Shah – See presentation | Expert Panel: Raphael Rosenhek, Erwan Donal
11:00 – 12:30 DEBATES ON HEART VALVE DISEASE DIAGNOSIS AND MANAGEMENT
11:00 That this House believes MVP SCD relates to diffuse myocardial fibrosis.
Chairs: Ariana Gozalez Gomez, Prof Andrew Grace
Proposition: Madalina Garbi – See presentation, Greg Mellor – See presentation | Expert Panel: Khalil Fattouch, Joseph Westaby
Opposition: Vass Vassiliou, Claire Martin – See presentation | Expert Panel: Covadonga Fernández-Golfín, Gilbert Habib
11:30 That this House believes multimodality imaging assessment and treatment are needed in suspected subclinical prosthetic valve thrombosis.
Chairs: Erwan Donal, Joelle Kefer
Proposition: Mauro Pepi – See presentation | Expert Panel: Dominik Schlosshan, Bobby Agrawal
Opposition: Marie-Annick Clavel – See presentation Expert Panel: Alain Berrebi, Jadranka Separovic
12:00 That this House believes HFpEF should be prevented by treating coexistent systemic hypertension, not early AVR.
Chairs: Prof Ian Wilkinson, Madalina Garbi
Proposition: George Athanassopoulos – See presentation | Expert Panel: Simon Ray, Benoy Shah
Opposition: Augustin Coisne – See presentation | Expert Panel: Erwan Donal, Mai-Linh Nguyen
14:30 – 15:00 FLASH NEWS
Chairs: Patrizio Lancellotti, Philippe Unger
14:30 EuroEndo Registry. Gilbert Habib
14:45 Sex differences in valve disease. Rebecca Hahn
15:00 – 15:30 DEBATABLE CASES
Chairs: Ariana Gozalez Gomez, Bobby Agarwal
Expert Panel: John Chambers, Patrizio Lancellotti, Luigia D’Errico, Thomas Treibel
15:00 Did echo make a complete diagnosis or we need more imaging? Nabila Naskar
15:10 Did exercise echo make a difference? Nico Van De Veire
15:20 Did MRI make a difference? Will Watson
15:30 Did CT make a difference? Harriet Hurrell – See presentation
16:00 – 17:30 DEBATES ON HEART VALVE DISEASE DIAGNOSIS AND MANAGEMENT
16:00 That this House believes severity threshold for intervention should differ in bicuspid aortic valve.
Chairs: Geu-Ru Hong, Marc Dweck
Proposition: Philippe Pibarot | Expert Panel: Madalina Garbi, Simon Ray
Opposition: Ariana Gozalez Gomez | Expert Panel: Patrizio Lancellotti, Clive Lewis
16:30 That this House believes aortic valve research should comply with the VARC3 definitions.
Chairs: Simon Ray, Marc Rademecker
Proposition: Agnes Pasquet | Expert Panel: Guy Lloyd, Mani Vannan
Opposition: Patrick Myers | Expert Panel: Augustin Coisne, Julia Grapsa
17:00 That this House believes compelling evidence for the role of cardiac MRI in HVD exists only for the assessment of the ventricles.
Chairs: Dominik Schlosshan, Julia Grapsa
Proposition: Laura Dobson | Expert Panel: Guy Lloyd, Luigia D’Errico
Opposition: Thomas Treibel | Expert Panel: Covadonga Fernández-Golfín, Will Watson
SATURDAY OCTOBER 8
09:00 – 10:30 DEBATES ON HEART VALVE DISEASE DIAGNOSIS AND MANAGEMENT
09:00 That this House believes transcatheter closure should be always the first option in paravalvular leak.
Chairs: Len Shapiro, Patrizio Lancellotti
Proposition: Patrick Calvert, Jeroen Bax | Expert Panel: Jan Kovac – See presentation – Alain Berrebi
Opposition: Milind Desai | Expert Panel: Sam Nashef, Marc Radermecker
09:30 That this House believes Ross procedure is the treatment of choice in young adults with bicuspid aortic valve.
Chairs: Clive Lewis, Conal Austin
Proposition: Serban Stoica – See presentation | Expert Panel: Marjan Jahangiri, Agnès Pasquet
Opposition: Ravi De Silva | Expert Panel: Marius Berman, Neil Cartwright
10:00 That this House believes surgical aortic valve replacement is the treatment of choice for aortic stenosis in patients predicted to have good surgical outcome and good life expectancy.
Chairs: David Philip Jenkins, Iqbal Malik
Proposition: Marjan Jahangiri – See presentation | Expert Panel: Khalil Fattouch, Joseph Zacharias – See presentation
Opposition: Mike O’Sullivan | Expert Panel: Thomas Modine, Mamta Buch
11:00 – 12:30 DEBATES ON HEART VALVE DISEASE DIAGNOSIS AND MANAGEMENT
11:00 That this House believes minimally invasive mitral valve surgery should be an option for patients with severe degenerative mitral regurgitation.
Chairs: Narain Moorjani (SCTS), Mani Vannan
Proposition: Joseph Zacharias – See presentation | Expert Panel: Steven Hunter, Max Baghai
Opposition: Francis Wells | Expert Panel: Norman Briffa, Marc Radermecker
11:30 That this House believes transcatheter edge-to-edge repair in ventricular-secondary mitral regurgitation can provide a bridge to transplantation.
Chairs: Marius Berman, Eustachio Agricola
Proposition: Mamta Buch (BHVS) – See presentation | Expert Panel: Felix Kreidel, Philippe Unger
Opposition: Stephen Pettit | Expert Panel: Patrizio Lancellotti, Gilbert Habib
12:00 That this House believes transcatheter techniques will prevail in the treatment of isolated tricuspid regurgitation.
Chairs: Jonathan Byrne, Patrizio Lancellotti
Proposition: Francesco Maisano | Expert Panel: Mike Mullen, Felix Kreidel
Opposition: Gilles Dreyfus | Expert Panel: Francis Wells, Marc Radermecker
14:30 – 15:30 CONTROVERSIES, DEBATES, GAPS IN VHD DIAGNOSIS AND MANAGEMENT
14:30 That this House believes transcatheter staged approach instead of surgery can be offered in multiple valve disease.
Chairs: Iqbal Malik, Max Baghai
Proposition: Charis Costopoulos – See presentation | Expert Panel: Philippe Unger, Jonathan Byrne
Opposition: Norman Briffa | Expert Panel: Paul Modi, Sam Nashef
15:00 That this House believes minimally invasive surgery should be considered for patients with previous sternotomy and patent LIMA, before transcatheter techniques.
Chairs: Khalil Fattouch, Mike Mullen
Proposition: Paul Modi – See presentation | Expert Panel: Marjan Jahangiri, Steven Hunter
Opposition: Jonathan Byrne | Expert Panel: Felix Kreidel, Mamta Buch
16:00 – 16:30 FLASH NEWS: COMPANY: EDWARDS
Optimizing the result of surgical AVR and of future valve-in-valve TAVI (Inspiris Resilia, aortic root enlargement). Max Baghai – See presentation, John Taghavi
16:30 – 17:00 OPTIMIZING THE RESULT OF TRANSCATHETER AVR AND MVR
Chairs: Charis Costopoulos, Mamta Buch
Speaker: Jaffar Khan
17:00 – 17:30 DEBATABLE SURPRISE IN A BOX CASES – WHAT SHOULD I DO? / WHAT DID I DO?
Chairs: Augustin Coisne, Patrizio Lancellotti
Expert Panel: Khalil Fattouch, Mamta Buch, Brian Campbell, Jonathan Weir-Mccall – See presentation
17:00 Surprise in a box
17:00 Surprise case 1. Charis Costopoulos – See presentation
17:10 Surprise case 2. Joseph Zacharias – See presentation
17:20 Surprise case 3. John Taghavi
17:30 Closing remarks